We are pleased to make available a couple of presentations that were first held during the EHA2022 Congress in Vienna. Presentations include; 'Non-BCR-ABL1 molecular biomarkers of prognosis in CML' and 'Mechanisms of disease progression in chronic myeloid leukemia'. |
![]() |
Non-BCR-ABL1 molecular biomarkers of prognosis in CML
|
This talk was first presented during the Scientific Working Group Session – ELN-EHA-SWG for CML: 'Understanding the pathogenesis of CML' at EHA 2022
![]() |
Mechanisms of disease progression in chronic myeloid leukemia Learning goals:
|
This talk was first presented during the Scientific Working Group Session – ELN-EHA-SWG for CML: 'Understanding the pathogenesis of CML' at EHA 2022